Fast-Tracking First-in-Human Trials, Anywhere
The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
Recent
Joseph Palumbo, Head of R&D & Chief Medical Officer at BioVie Inc
In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vi…
Joseph Palumbo, Head of R&D & Chief Medical Officer at BioVie Inc
- Background and career: Dr. Palumbo is a physician-scientist with 30+ years leading programs in psychiatry, neurology, and neurodegenerative disease across Johnson & Johnson/Janssen, Mitsubishi Tanabe, Zynerba, and BioVie, with contributions to FDA registrations such as Risperdal Consta, Invega, I…
Nicholas Kadysh, CEO at PharmAla Biotech
In this episode, we sit down with Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and recognized as the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has played a pivotal role in str…
Nicholas Kadysh, CEO at PharmAla Biotech
- Guest: Nicholas Kadysh, CEO of PharmAla Biotech, a company pioneering GMP-grade MDMA production and recognized as a top-performing Canadian market stock in 2023. He also serves as Chair of Psychedelics Canada, leading efforts to strengthen legal and ethical standards and advance government engage…
Carolina Alarco, Founder & Principal, Bio Strategy Advisors
Carolina is a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. She is the Founder & Principal of Bio Strategy Advisors, a strategic consulting firm specializing in start-up formation, corporate strategy, strategic partnerships, and global expansion. She …
Carolina Alarco, Founder & Principal, Bio Strategy Advisors
In this episode, we sit down with Carolina Alarco, a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. Carolina is the Founder & Principal of Bio Strategy Advisors, serves on multiple biotech and nonprofit boards, and is the Co-Founder & Co-Chair of Latino…
Listen On
Recent Blog Posts
Dr. Joseph Palumbo's Journey: From Psychiatry to Neurodegenerative Re…
Welcome to the blog! In this post, we'll be exploring the extraordinary career of Dr. Joseph Palumbo, a true pioneer in the fields of psychiatry, neurology, and neurodegenerative research. From his early work to his current role at BioVie, Dr. Palum…
PharmAla Biotech: Leading the Charge in GMP MDMA Production
Welcome to this blog post, a companion piece to our recent podcast episode featuring Nicholas Kadysh, CEO of PharmAla Biotech. In this episode, which you can listen to here, we delved into PharmAla Biotech's groundbreaking work in revolutionizing GM…
Navigating the Complexities of Biotech Strategy: Key Insights from Ca…
Welcome to the blog, where we delve deeper into the fascinating topics covered on our podcast. Today, we're unpacking the intricate world of biotech strategy, drawing on the insightful conversation we had with Carolina Alarco, Founder & Principa…
About the Host
Julio G Martinez-Clark
CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.